CGT-2026

We cordially invite you to the Global Cell & Gene Therapy Summit-2026, taking place in Boston, MA, from July 6-8, 2026.

Speakers

Howard Federoff
Howard Federoff
Chief Medical Officer & Co-Founder

Kenai Therapeutics, FL

Jim McNally
Jim McNally
Chief Scientific Officer

Sword Bio, MA

Vladimir Slepushkin
Vladimir Slepushkin
Chief Technology Officer

MedTherapy Biotech, MA

Priya Baraniak
Priya Baraniak
Chief Commercial and Development Officer

Pluristyx, Inc., PA

Alessandra De Riva
Alessandra De Riva
Head of Process Development and R&D

Advent Bioservices, UK

Daniel J.Kota
Daniel J.Kota
Director, Office of Translational Production and Quality

Houston Methodist, TX

Chris Mason
Chris Mason
Professor of Cell & Gene Therapy

University College of London, UK

Amir Hefni
Amir Hefni
Chief Executive Officer

Resolution Therapeutics, UK

Emmanuelle Cameau
Emmanuelle Cameau
Scientific Director - Viral vectors and other modalities

Cytiva, France

Jane Andrews
Jane Andrews
CEO & Founder

Cell Bridge Strategies, TX

Sally Gu
Sally Gu
Senior Associate, Life Sciences/FDA

Hogan Lovells, DC

Yu Cao
Yu Cao
VP, Global Head of Drug Discovery

GenEditBio Limited, MA

John Boyce
John Boyce
Managing Director and Co-Founder

TigerGene LLC, MA

John Zhao
John Zhao
Director Process Development

Kytopen, MA

Cassandra Perkins
Cassandra Perkins
Director, Value & Access, Channel, Distribution Consulting; Cell & Gene Therapy Consulting

Syneos Health, NC

Larry Forman
Larry Forman
Founder and CEO

CHO Plus, Inc., CA